UK Medical Cannabis Awareness Month: Campaigners, Clinicians and Industry Leaders Join Forces to Drive Momentum
A quick rundown of the highlights so far, and what’s still left to look forward to.
24 results for “clinicians”
A quick rundown of the highlights so far, and what’s still left to look forward to.
Healthcare professionals attending the Cannabis Health Symposium next month will be able to earn CPD points to support their professional development. The Cannabis Health Symposium is a Continuing Professional Development […]
The Medical Cannabis Clinicians Society (MCCS) and Curaleaf Laboratories have formed a new partnership aimed at addressing critical knowledge gaps.
UK medical professionals are invited to take part in a new outreach project
Over 300 health professionals have signed up to learn more about medical cannabis.
Fifty medical professionals have signed an open letter expressing their concerns over the BPNA guidelines
Clinicians believe that cannabis has medicinal uses, but knowledge of the scientific evidence is lacking
Europe’s dedicated medical cannabis education series for clinicians and industry professionals announces two autumn events — 4 November at Mainhaus, Frankfurt, and 26 November at Conway Hall, London
We take a closer look at the data behind medical cannabis prescribing to examine what it can reliably show us.
Clinicians, scientists and patients explored whether medical cannabis could help address longstanding inequalities in women’s health.
Medical cannabis patients are often framed as consumers chasing the next strain, but that overlooks how many navigate treatment, writes Dave Barton.
In a new multi-clinic survey, the majority of patients report improvements in their symptoms.
Inspectors found breaches in care, governance, and oversight at a private medical cannabis clinic.
Researchers have identified a potential mechanism linked to a reduced risk of type 2 diabetes.
Dr Sue Clenton, Medical Director at Releaf Cannabis Clinic, shares her insight from the frontline of an emerging field of medicine.
More than 70 international speakers and over 1000 delegates are set to convene on London next month for policy debates, high-level networking, and the 2026 Business of Cannabis Awards.
Less than 100 patients have been approved for medical cannabis treatment under the MCAP scheme.
A new campaign is calling for urgent regulatory changes to how medical cannabis is prescribed to psychiatric patients in the UK.
By Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf […]
Researchers concluded that the available evidence rarely justifies the routine prescribing of cannabinoids for mental health conditions.
In a fascinating deep dive into human physiology, Dr. Rowan Thompson, resident doctor and Vice Chair of the Medical Cannabis Clinicians Society (MCCS), explores the Endocannabinoid System (ECS)—a complex biological […]
Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine.
It is believed to be one of the first student-selected medical cannabis teaching placements offered by a UK university.
FOD is thought to affect an estimated 41% of women, but experts say it has been historically under-treated.